Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Pharmaceutical excipients polyethylene glycol?

See the DrugPatentWatch profile for polyethylene

Polyethylene glycol (PEG) is a widely used excipient in pharmaceutical formulations, serving multiple functions [1]. It is a polymer of ethylene oxide and can be found in various molecular weights, which influence its physical properties and applications [2].

What role does polyethylene glycol play in medications?


PEG's versatility allows it to act as a solvent, solubilizer, surfactant, lubricant, and plasticizer in drug products [1]. Its ability to dissolve both water-soluble and water-insoluble drugs makes it valuable for enhancing bioavailability [3]. Different molecular weights of PEG are chosen based on the specific formulation needs, with lower molecular weights generally being more soluble and lower viscosity, while higher molecular weights are more viscous and can act as binders or matrix formers [4].

How is polyethylene glycol used in different drug delivery systems?


In oral dosage forms, PEG can improve the solubility of poorly soluble active pharmaceutical ingredients (APIs), leading to better absorption [3]. It is also used as a binder in tablets and as a lubricant to aid in tablet manufacturing [1]. For topical applications, PEG can act as a base for ointments and creams, providing a smooth texture and aiding in drug penetration [5]. In injectable formulations, PEG is used to increase the solubility and stability of certain drugs [2]. Furthermore, PEGylation, the process of attaching PEG chains to proteins or peptides, is a common technique to improve their pharmacokinetic properties, such as increasing their circulation half-life and reducing immunogenicity [6].

Are there different types of polyethylene glycol used in pharmaceuticals?


Yes, PEG exists in various grades and molecular weights, commonly ranging from 200 to over 10,000 g/mol [4]. Pharmaceutical-grade PEGs must meet strict purity standards [7]. For instance, PEG 3350 and PEG 400 are frequently used. PEG 3350 is a solid at room temperature and often used in laxative preparations, while PEG 400 is a liquid and commonly employed as a solubilizer in liquid formulations and injectables [8].

What are the safety considerations for polyethylene glycol in medicines?


PEG is generally considered safe and well-tolerated by the body [1]. However, some individuals may experience gastrointestinal side effects, such as bloating or diarrhea, particularly with oral laxative preparations containing PEG [9]. Allergic reactions, though rare, have been reported [10]. The safety and suitability of PEG as an excipient are evaluated by regulatory bodies like the U.S. Food and Drug Administration (FDA) [7].

When does patent exclusivity expire for drugs using polyethylene glycol?


The patent exclusivity for a drug is determined by the patents protecting the active pharmaceutical ingredient (API) itself, or sometimes specific formulations or manufacturing processes. The presence of polyethylene glycol as an excipient does not typically grant independent patent protection that would extend the drug's market exclusivity beyond that of the API. Patent expiration timelines are specific to each drug and can be tracked through resources like DrugPatentWatch.com [11].

What are some alternatives to polyethylene glycol in pharmaceutical formulations?


Depending on the intended function, alternative excipients can be considered. For solubilization, other polymers like cyclodextrins or surfactants such as polysorbates may be used [12]. For tablet lubrication, magnesium stearate is a common alternative [1]. For topical bases, petrolatum or various waxes could be employed [5]. The choice of an alternative depends heavily on the specific drug properties and desired delivery characteristics.

Sources:

1. https://www.drugpatentwatch.com/blog/understanding-pharmaceutical-excipients-polyethylene-glycol-peg
2. https://www.drugpatentwatch.com/blog/polyethylene-glycol-as-a-pharmaceutical-excipient-a-comprehensive-review
3. https://www.drugpatentwatch.com/blog/impact-of-excipients-on-drug-solubility-and-bioavailability
4. https://www.drugpatentwatch.com/blog/polyethylene-glycol-molecular-weights-and-their-pharmaceutical-applications
5. https://www.drugpatentwatch.com/blog/polyethylene-glycol-in-topical-formulations-enhancing-drug-delivery-to-the-skin
6. https://www.drugpatentwatch.com/blog/pegylation-technology-advancing-biologics-and-protein-therapeutics
7. https://www.drugpatentwatch.com/blog/regulatory-requirements-for-pharmaceutical-excipients
8. https://www.drugpatentwatch.com/blog/common-grades-of-polyethylene-glycol-used-in-pharmaceuticals
9. https://www.drugpatentwatch.com/blog/understanding-the-side-effects-of-polyethylene-glycol-in-medications
10. https://www.drugpatentwatch.com/blog/rare-adverse-events-associated-with-pharmaceutical-excipients
11. https://www.drugpatentwatch.com/
12. https://www.drugpatentwatch.com/blog/innovative-solubilizers-for-drug-formulation



Other Questions About Polyethylene :

polyethylene glycol 6000 excipient polyethylene oxide market activated polyethylene glycol market polyethylene glycol market polyethylene glycol 6000 pharmacology excipient Can i give polyethylene glycol to a toddler? Is polyethylene glycol for constipation?